Women’s health, especially their sexual and reproductive health, have long been a hushed topic in India. This veil of silence comes at a cost—the lack of awareness deters women from getting tested for HPV and tackling health issues like cervical cancer that can, in fact, be prevented. Cervical Cancer is the second most common cancer that affects women in India he World Health Organization has identified cervical cancer as a major public health issue in India. In 2021, the WHO and India set a goal to eliminate cervical cancer in the country by 2030. However, one of the biggest hurdles is the lack of screening centers across India's vast geography and the asymptomatic nature of the disease in its early stages. Achieving the WHO’s 2030 elimination targets will require breaking down societal barriers that have kept women’s health cloaked for so long. We need to normalize conversations around sexual and reproductive health to drive more informed decisions and lifesaving action among women. There are encouraging signs of change, but continued awareness and advocacy around women’s health issues remain vital on the path ahead.
Unmasking Silent Risks
Nearly everyone who is sexually active will encounter the Human Papillomavirus (HPV) at some point during their lifetime, but only certain strains of this virus could potentially cause cervical cancer
The good news is, unlike many other kinds of malignancies, is preventable and also highly treatable, if diagnosed early and managed effectively. Breakthrough ech innovations are allowing you to stay ahead of your health issues by signaling potential risks. Proactive measures like screening and testing regularly can make a life-saving difference in diagnosing risk and taking action to curb it. Today, testing is not merely about detecting the presence or absence of a health condition; it's a tool that empowers healthcare professionals to understand the possibility of specific health issues as well as determine treatment options for improved outcomes. Let’s find out how.
The Story Our Genes Tell
The Pap smear has been regarded as the gold standard for assessing cervical health, and examining cervical cells for any changes that might lead to cancer. We are now witnessing the emergence of HPV screening, a form of molecular HPV testing, which can supplement existing testing methodologies to herald a new era in diagnostics.
Each type of HPV possesses a unique genetic signature, known as a genotype. Understanding which genotype causes an infection is crucial in evaluating the likelihood of the infection progressing to cancer. Out of the numerous genotypes, 14 are classified as high risk (HR) due to their carcinogenic potential. Sophisticated HR HPV tests today help in identifying some of these cancer-causing strains of HPV, to present a reliable roadmap for protection against cervical cancer. If an individual tests positive for the highest-risk HPV genotypes, they might be fast-tracked into a management plan, potentially involving a colposcopy and biopsy to analyze the cervix. On the other hand, if the test identifies a lower-risk genotype, your healthcare provider can monitor y, adjusting the therapeutic approach based on the level of risk involved. These tests thus provide critical information that allows healthcare providers to help women tackle health problems even before they occur.
The advent of a vaccine to prevent HPV has further bolstered efforts in fighting cervical cancer. Vaccination against HPV is a powerful tool, especially when administered between the ages of 9 to 14 years, HPV infections, cervical cancer, and other related cancers. It is important to remember though that regular screening must continue, even after the administration of the vaccine. Screening from the age of 30 (25 for women living with HIV) becomes a crucial defense, detecting cervical disease early on and preventing progression.
In a world where information is power, this kind of futuristic testing provides a solid foundation for managing and preventing cervical cancer, guiding patients and healthcare providers toward the most effective and personalized care plans, to help more people live fully. The emergence of HPV testing innovations a significant stride forward in the quest for better women's health.
With molecular HPV testing leading the way, women are empowered to take charge of their health and navigate their well-being confidently. With health tech by our side, it’s time to envision a world where conversations about reproductive health are as routine as AI innovations discussed over coffee. It is our duty to nurture and cultivate a awareness and health takes center stage.
Disclaimer: The information mentioned in this document is only suggestive /for patient education and shall not be considered as a substitute for doctor’s advice or recommendations from Abbott. Please consult your doctor for more information.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.
The website that you have requested also may not be optimized for your screen size.
FOLLOW ABBOTT